Evaluation of everolimus (EVE) in HER2+advanced breast cancer (BC) with activated PI3K/mTOR pathway: Exploratory biomarker observations from the BOLERO-3 trial

---

Copy For Citation

Jerusalem G., Andre F., Chen D., Robinson D., Ozguroglu M., Lang I., ...More

EUROPEAN JOURNAL OF CANCER, vol.49, 2013 (SCI-Expanded)

• Publication Type: Article / Abstract
• Volume: 49
• Publication Date: 2013
• Journal Name: EUROPEAN JOURNAL OF CANCER
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Istanbul University Affiliated: Yes